Hong_2017_Diabetes.Obes.Metab_19_654

Reference

Title : Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extension - Hong_2017_Diabetes.Obes.Metab_19_654
Author(s) : Hong SM , Park CY , Hwang DM , Han KA , Lee CB , Chung CH , Yoon KH , Mok JO , Park KS , Park SW
Ref : Diabetes Obes Metab , 19 :654 , 2017
Abstract : Hong_2017_Diabetes.Obes.Metab_19_654
ESTHER : Hong_2017_Diabetes.Obes.Metab_19_654
PubMedSearch : Hong_2017_Diabetes.Obes.Metab_19_654
PubMedID: 28058750

Related information

Citations formats

Hong SM, Park CY, Hwang DM, Han KA, Lee CB, Chung CH, Yoon KH, Mok JO, Park KS, Park SW (2017)
Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extension
Diabetes Obes Metab 19 :654

Hong SM, Park CY, Hwang DM, Han KA, Lee CB, Chung CH, Yoon KH, Mok JO, Park KS, Park SW (2017)
Diabetes Obes Metab 19 :654